All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0057 | Anti-DDX3X (3B9E3) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3B9E3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0058 | Anti-DDX3X (11F11D10) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 11F11D10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0059 | Anti-DDX3X (3B9G8) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 3B9G8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0060 | Anti-DDX3X (2253C5a) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2253C5a | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0061 | Anti-DDX3X (Y4C) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | Y4C | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0062 | Anti-DDX3X (8C101) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8C101 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0957 | Anti-DDX3X (3B9E3) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3B9E3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0958 | Anti-DDX3X (11F11D10) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 11F11D10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0959 | Anti-DDX3X (3B9G8) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 3B9G8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0960 | Anti-DDX3X (2253C5a) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2253C5a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0961 | Anti-DDX3X (Y4C) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | Y4C | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0962 | Anti-DDX3X (8C101) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 8C101 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION